Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Total Current Liabilities (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Total Current Liabilities for 5 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities rose 10.14% year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Sep 2025, up 10.14%, and an annual FY2024 reading of $894263.0, up 10.46% over the prior year.
  • Total Current Liabilities was $1.1 million for Q3 2025 at Xenetic Biosciences, up from $903430.0 in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.6 million in Q2 2024 and bottomed at $667927.0 in Q1 2025.
  • Average Total Current Liabilities over 3 years is $954241.8, with a median of $894263.0 recorded in 2024.
  • The sharpest move saw Total Current Liabilities soared 82.21% in 2024, then plummeted 43.09% in 2025.
  • Year by year, Total Current Liabilities stood at $809585.0 in 2023, then grew by 10.46% to $894263.0 in 2024, then rose by 24.32% to $1.1 million in 2025.
  • Business Quant data shows Total Current Liabilities for XBIO at $1.1 million in Q3 2025, $903430.0 in Q2 2025, and $667927.0 in Q1 2025.